Blood Protein Adiponectin and Heart Attack or Stroke Risk in Chinese Adults
Studies adiponectin, a blood protein, and its link to heart attack and stroke.
Plain-language title generated from the registry record
Registry title: Serum Adiponectin in Chinese Population and Its Correlation to Cardiovascular and Cerebrovascular Diseases
Key facts
- Where
- Xi'an, ChinaSee the site
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 85 years old?
Source: NCT01372800, who can take part
Where in China
- Xijing hospitalXi'an, ChinaTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Xijing Hospital
- Trial code
- NCT01372800
- Record updated
- 7 February 2025
- Original description
Adiponectin (Ad) is an abundant protein in human body, and reports have shown that it act as a novel risk factor for brain and heart ischemia injury. This 5 years follow-up study will focus on serum adiponectin concentration, activity and isoforms in Chinese population and its correlation to these diseases.Read full original descriptionShow less
Serum Adiponectin Concentration, Activity and Isoforms in Chinese Population and Its Correlation to Cardiovascular and Cerebrovascular Diseases
Adiponectin (Ad) is an abundant protein in human body, and reports have shown that it act as a novel risk factor for brain and heart ischemia injury. This 5 years follow-up study will focus on serum adiponectin concentration, activity and isoforms in Chinese population and its correlation to these diseases.
Inclusion: available for 5 years of follow-up study.
Exclusion: Death caused other than cardiovascular and cerebralvascular diseases till the study ends; Active hepatic disease or hepatic dysfunction, or AST/ALT > 1.5UNL; Severe renal dysfunction(Scr > 3 mg/dl or 264μmol/L); Patients with any condition which, in the investigator's judgment, might increase the risk to the subject for any adverse event or abnormal laboratory finding; Floating Population; Pregnancy, lactation, or child bearing women; Tumor.